Affiliation:
1. Department of Internal Medicine Cardiovascular and Immunologic Sciences, University of Naples Federico II, 80138 Naples, Italy
2. Physiopathology Chair, Homeopathic Medical School of Verona, 37121 Verona, Italy
Abstract
Recently, in Italy, a flowchart to be used by General Practitioners for the at-home treatment of patients with COVID-19, has been released. It states that early at-home treatment for SARS-CoV-2 infection is possible due to the availability of specific antiviral drugs to be used in at-risk patients, and that non-steroidal anti-inflammatory drugs (NSAIDs) have an important function in combating the virus. Therefore, the use of NSAIDs is not only rational but also effective in cases that cannot be treated using antivirals. These seemingly simple concepts have been applied in Italy since the beginning of the pandemic by doctors that belong to Italian groups created in order to help COVID-19 patients early at home, at a time of organizational difficulties within Italian health institutions and government. However, this approach was largely boycotted by both the Italian Ministry of Health and medical institutions, which mainly suggested the use of paracetamol as symptomatic, and a wait-and-watch approach for the first three days from the onset of symptoms. In this article, we analyze the rationale for the use of NSAIDs and, in particular, the multi-targeted approach including indomethacin in synergism with flavonoids and low-dose aspirin, as early at-home treatment of patients with COVID-19. Applying these simple concepts from the beginning could have reduced the high lethality of the disease during the first two years of the pandemic and prevented hospital overload. In perspective, it is still necessary to systematically address the comparison between different therapeutic approaches to this viral disease on an experimental basis.
Reference145 articles.
1. Evidence-Based Medicine Working Group (1992). Evidence-Based medicine. A new approach to teaching the practice of medicine. JAMA, 268, 2420–2425.
2. Straus, S.E., Glasziou, P., Richardson, W.S., and Haynes, R.B. (2011). Evidence-Based Medicine: How to Practice and Teach It, Elsevier. [4th ed.].
3. SARS-CoV-2 and the pandemic of COVID-19;Adil;Postgrad. Med. J.,2021
4. COVID-19: Off-label therapies based on mechanism of action while waiting for evidence-based medicine recommendations;Morrone;World J. Meta Anal.,2020
5. The Problem of Home Therapy during COVID-19 Pandemic in Italy: Government Guidelines versus Freedom of Cure?;Fazio;J. Pharm. Pharmacol. Res.,2022
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献